Goldman Sachs, Evercore ISI and Morgan Stanley acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BBIO:
- Ascendis Pharma has positive read-through from BridgeBio data, says BofA
- 3 Stocks to Buy Today, 3/7/2023, According to Top Analysts
- Tyra Biosciences has positive read-through from BridgeBio data, says BofA
- BridgeBio price target raised to $18 from $15 at BofA
- BridgeBio Pharma Announces Proposed Public Offering of Common Stock